Cancer Biomarkers (häftad)
Format
Häftad (Paperback / softback)
Språk
Engelska
Antal sidor
250
Utgivningsdatum
2007-04-01
Upplaga
illustrated ed
Förlag
National Academies Press
Medarbetare
Committee on Developing Biomarker-Based Tools for Cancer Screening, Diagnosis, and Treatment (creator)/National Academy of Sciences (creator)/Committee on Developing Biomarker-Based Tools for Cancer Screening, Diagnosis, and Treatment (creator)/National Academy of Sciences (creator)
Illustrationer
Illustrations
Dimensioner
226 x 156 x 14 mm
Vikt
400 g
Antal komponenter
1
ISBN
9780309103862

Cancer Biomarkers

The Promises and Challenges of Improving Detection and Treatment

Häftad,  Engelska, 2007-04-01
492
  • Skickas från oss inom 5-8 vardagar.
  • Fri frakt över 249 kr för privatkunder i Sverige.
Finns även som
Visa alla 2 format & utgåvor
Many cancer patients are diagnosed at a stage in which the cancer is too far advanced to be cured, and most cancer treatments are effective in only a minority of patients undergoing therapy. Thus, there is tremendous opportunity to improve the outcome for people with cancer by enhancing detection and treatment approaches. Biomarkers will be instrumental in making that transition. Advances in biotechnology and genomics have given scientists new hope that biomarkers can be used to improve cancer screening and detection, to improve the drug development process, and to enhance the effectiveness and safety of cancer care by allowing physicians to tailor treatment for individual patients&#8212an approach known as personalized medicine. However, progress overall has been slow, despite considerable effort and investment, and there are still many challenges and obstacles to overcome before this paradigm shift in oncology can become a reality. Table of Contents Front Matter Summary 1 Introduction 2 Methods, Tools, and Resources Needed to Discover and Develop Biomarkers 3 Guidelines, Standards, Oversight, and Incentives Needed for Biomarker Development 4 Methods and Process Needed for Clinical Adoption and Evaluation of Biomarker-Based Diagnostics Acronyms and Glossary Appendix: Developing Biomarker-Based Tools for Cancer Screening, Diagnosis,and Treatment: The State of the Science, Evaluation, Implementation, and Economics, Workshop Summary--Margie Patlak and Sharyl Nass, Rapporteurs
Visa hela texten

Passar bra ihop

  1. Cancer Biomarkers
  2. +
  3. Co-Intelligence

De som köpt den här boken har ofta också köpt Co-Intelligence av Ethan Mollick (häftad).

Köp båda 2 för 720 kr

Kundrecensioner

Har du läst boken? Sätt ditt betyg »

Övrig information

Committee on Developing Biomarker-Based Tools for Cancer Screening, Diagnosis, and Treatment, Sharyl J. Nass and Harold L. Moses, Editors

Innehållsförteckning

1 Front Matter; 2 Summary; 3 1 Introduction; 4 2 Methods, Tools, and Resources Needed to Discover and Develop Biomarkers; 5 3 Guidelines, Standards, Oversight, and Incentives Needed for Biomarker Development; 6 4 Methods and Process Needed for Clinical Adoption and Evaluation of Biomarker-Based Diagnostics; 7 Acronyms and Glossary; 8 Appendix: Developing Biomarker-Based Tools for Cancer Screening, Diagnosis,and Treatment: The State of the Science, Evaluation, Implementation, and Economics, Workshop Summary--Margie Patlak and Sharyl Nass, Rapporteurs